US Patent Issued to ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) on Jan. 27 for "TEIPP peptide variant and use as a medicament" (Dutch Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,497, issued on Jan. 27, was assigned to ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) (Leiden, Netherlands).

"TEIPP peptide variant and use as a medicament" was invented by Thorbald Van Hall (Leiden, Netherlands), Sjoerd Henricus Van Der Burg (Leiden, Netherlands) and Koen Marjit (Leiden, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel nucleic acid sequences, vectors, cells, binding agents, peptides and pharmaceutical compositions are provided that are useful as a medicament, for example in the prevention or treatment of cancer or viral infections associated with impaired HLA class I antigen presentation. Corresponding methods and us...